Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by Lazorsharpon Dec 09, 2019 11:14am
128 Views
Post# 30435830

VFF 100% OF PSF

VFF 100% OF PSFLet's say EMH takes the 25% as per agreement @$5.00 a gram Q1 2020, PSF makes a killing, that's one quarter. Now can EMH do this for the remainder of the agreement until 2022 that's 11 more quarters. Personaly I don't see what they can't, although here is little "caveat" in the agreement with EMH they are required to pay upfront for the product, which is a big cash flow problem for EMH who has, lets face it, less than desirable financials. Q1 2020 EMH would have to pay PSF roughly around $35 million for the 25% as per agreement @$5 a gram.
<< Previous
Bullboard Posts
Next >>